✦ LIBER ✦

Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography

✍ Scribed by Lindner, J.; Hillmann, K.; Blume-Peytavi, U.; Lademann, J.; Lux, A.; Stroux, A.; Schneider, A.; Garcia Bartels, N.

Book ID: 119833723
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 505 KB
Volume: 167
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2012.11180.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hair shaft abnormalities in alopecia are

Hair shaft abnormalities in alopecia areata evaluated by optical coherence tomography

✍ Natalie Garcia Bartels; Irina Jahnke; Alexa Patzelt; Heike Richter; Jürgen Ladem 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Evaluation of the Radiation Therapy–Indu

Evaluation of the Radiation Therapy–Induced Optic Nerve and Chiasm Injuries by Electrophysiological Tests and Optic Coherence Tomography in the Patients With Nasopharyngeal Carcinoma

✍ Ozkaya Akagunduz, O.; Guven Yilmaz, S.; Demirkilinc Biler, E.; Afrashi, F.; Esas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

GYNECOMASTIA AND BREAST PAIN INDUCED BY

GYNECOMASTIA AND BREAST PAIN INDUCED BY ADJUVANT THERAPY WITH BICALUTAMIDE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PROSTATE CANCER: THE ROLE OF TAMOXIFEN AND RADIOTHERAPY

✍ DI LORENZO, GIUSEPPE; PERDONÀ, SISTO; DE PLACIDO, SABINO; D’ARMIENTO, MASSIMO; G 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 705 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b